Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset.

Oral oncology - 1 Jun 2009

Hamid Sharifah, Yang Yi-Hsin, Peng Karen Ng Lee, Ismail Siti Mazlipah, Zain Rosnah Binti, Lim Kue Peng, Wan Mustafa Wan Mahadzir, Abraham Mannil Thomas, Teo Soo-Hwang, Cheong Sok Ching

Abstract excerpt

The MDM2 SNP309 has been associated with increased expression of the protein which could suppress p53 function, and has been shown to modulate risk to cancer. We have previously shown that overexpression of MDM2 is a common event in oral cancers. In the present study, we determined the association between the MDM2 SNP309 polymorphism and oral cancer in 207 oral cancer patients and 116 normal subjects. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Malaysia

Share to Mouth Neoplasms

Share to Odds Ratio

Share to Polymorphism, Restriction Fragment Length

Share to Proto-Oncogene Proteins c-mdm2

Source

Identifiers

PMID: 18804411
DOI: 10.1016/j.oraloncology.2008.06.003

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset.PMID 18804411Read ↗

Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Impact of MDM2 single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinoma.Semantic proximity Read ↗

MDM2 SNP309 G allele decreases risk but does not affect onset age or survival of Chinese leukaemia patients.Semantic proximity Read ↗

Impact of MDM2 single nucleotide polymorphism on oral squamous cell carcinoma risk.Semantic proximity Read ↗

Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing.Semantic proximity Read ↗

Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma.Semantic proximity Read ↗

MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population.Semantic proximity Read ↗

Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma.Semantic proximity Read ↗

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.Semantic proximity Read ↗

Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma.Semantic proximity Read ↗

No association between SNP309 promoter polymorphism in the MDM2 and cervical cancer in a study from northeastern Brazil.Semantic proximity Read ↗

No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.